PBCRF(PBCRF)
PBCRF
No analyst ratings available
No analyst price targets available for PBCRF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $118.43T | $128.17T | $139.28T |
| Low | $115.38T | $123.62T | $134.98T |
| High | $120.70T | $134.18T | $143.95T |
| EBITDA Avg | $84.71T | $91.68T | $99.63T |
| Low | $82.53T | $88.42T | $96.56T |
| High | $86.34T | $95.98T | $102.97T |
| EBIT Avg | $83.19T | $90.04T | $97.84T |
| Low | $81.05T | $86.84T | $94.82T |
| High | $84.79T | $94.25T | $101.12T |
| Net Income Avg | $60.73T | $66.45T | $73.21T |
| Low | $58.30T | $63.78T | $70.27T |
| High | $63.38T | $69.35T | $76.40T |
| EPS Avg | $492.67 | $539.03 | $593.85 |
| Low | $472.91 | $517.41 | $570.03 |
| High | $514.15 | $562.53 | $619.74 |
| Analysts (Rev / EPS) | 20 / 1 | 21 / 1 | 17 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $29.50T | $30.46T | $30.91T | $31.61T |
| Low | $29.50T | $30.46T | $30.91T | $31.61T |
| High | $29.50T | $30.46T | $30.91T | $31.61T |
| EBITDA Avg | $21.10T | $21.79T | $22.11T | $22.61T |
| Low | $21.10T | $21.79T | $22.11T | $22.61T |
| High | $21.10T | $21.79T | $22.11T | $22.61T |
| EBIT Avg | $20.72T | $21.40T | $21.71T | $22.21T |
| Low | $20.72T | $21.40T | $21.71T | $22.21T |
| High | $20.72T | $21.40T | $21.71T | $22.21T |
| Net Income Avg | $866M | $872M | $926M | $938M |
| Low | $866M | $872M | $926M | $938M |
| High | $866M | $872M | $926M | $938M |
| EPS Avg | $125.86 | $126.71 | $134.56 | $136.31 |
| Low | $125.86 | $126.71 | $134.56 | $136.31 |
| High | $125.86 | $126.71 | $134.56 | $136.31 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |